226 related articles for article (PubMed ID: 20198471)
1. D-Serine and a glycine transporter-1 inhibitor enhance social memory in rats.
Shimazaki T; Kaku A; Chaki S
Psychopharmacology (Berl); 2010 Apr; 209(3):263-70. PubMed ID: 20198471
[TBL] [Abstract][Full Text] [Related]
2. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
Karasawa J; Hashimoto K; Chaki S
Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
[TBL] [Abstract][Full Text] [Related]
3. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
[TBL] [Abstract][Full Text] [Related]
4. Modulation of glycine sites enhances social memory in rats using PQQ combined with d-serine.
Zhou X; Liu D; Zhang R; Peng Y; Qin X; Mao S
Behav Brain Res; 2016 Jul; 308():217-21. PubMed ID: 27109337
[TBL] [Abstract][Full Text] [Related]
5. Modulation of striatal dopamine release in vitro by agonists of the glycineB site of NMDA receptors; interaction with antipsychotics.
Bennett S; Gronier B
Eur J Pharmacol; 2005 Dec; 527(1-3):52-9. PubMed ID: 16307739
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action.
Javitt DC; Duncan L; Balla A; Sershen H
Mol Psychiatry; 2005 Mar; 10(3):275-87. PubMed ID: 15278098
[TBL] [Abstract][Full Text] [Related]
7. The glycine transporter type 1 inhibitor N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior.
Kinney GG; Sur C; Burno M; Mallorga PJ; Williams JB; Figueroa DJ; Wittmann M; Lemaire W; Conn PJ
J Neurosci; 2003 Aug; 23(20):7586-91. PubMed ID: 12930797
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex.
Konradsson A; Marcus MM; Hertel P; Svensson TH; Jardemark KE
Synapse; 2006 Aug; 60(2):102-8. PubMed ID: 16715496
[TBL] [Abstract][Full Text] [Related]
9. Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo.
Chen L; Muhlhauser M; Yang CR
J Neurophysiol; 2003 Feb; 89(2):691-703. PubMed ID: 12574447
[TBL] [Abstract][Full Text] [Related]
10. Effect of Sarcosine (a Glycine Transport 1 Inhibitor) and Risperidone (an Atypical antipsychotic Drug) on MK-801 Induced Learning and Memory Deficits in Rats.
Kumar V; Ahmad MA; Najmi AK; Akhtar M
Drug Res (Stuttg); 2016 Jan; 66(1):11-7. PubMed ID: 25710578
[TBL] [Abstract][Full Text] [Related]
11. Probing the modulation of acute ethanol intoxication by pharmacological manipulation of the NMDAR glycine co-agonist site.
Debrouse L; Hurd B; Kiselycznyk C; Plitt A; Todaro A; Mishina M; Grant SG; Camp M; Gunduz-Cinar O; Holmes A
Alcohol Clin Exp Res; 2013 Feb; 37(2):223-33. PubMed ID: 22934986
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia.
Chaki S; Shimazaki T; Karasawa J; Aoki T; Kaku A; Iijima M; Kambe D; Yamamoto S; Kawakita Y; Shibata T; Abe K; Okubo T; Sekiguchi Y; Okuyama S
Psychopharmacology (Berl); 2015 Aug; 232(15):2849-61. PubMed ID: 25869273
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site.
Shim SS; Hammonds MD; Kee BS
Eur Arch Psychiatry Clin Neurosci; 2008 Feb; 258(1):16-27. PubMed ID: 17901997
[TBL] [Abstract][Full Text] [Related]
14. Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia.
Labrie V; Lipina T; Roder JC
Psychopharmacology (Berl); 2008 Oct; 200(2):217-30. PubMed ID: 18597079
[TBL] [Abstract][Full Text] [Related]
15. Effects of antipsychotic treatments and D-serine supplementation on the electrophysiological activation of midbrain dopamine neurons induced by the noncompetitive NMDA antagonist MK 801.
Bennett S; Gronier B
Synapse; 2007 Aug; 61(8):679-88. PubMed ID: 17523181
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
17. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1).
Manahan-Vaughan D; Wildförster V; Thomsen C
Eur J Neurosci; 2008 Oct; 28(7):1342-50. PubMed ID: 18973561
[TBL] [Abstract][Full Text] [Related]
18. Glycine transporter blockade ameliorates motor ataxia in a mouse model of spinocerebellar atrophy.
Tanabe M; Nakano T; Honda M; Ono H
J Pharmacol Sci; 2009 Mar; 109(3):444-8. PubMed ID: 19270429
[TBL] [Abstract][Full Text] [Related]
19. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine.
Hashimoto K; Fujita Y; Ishima T; Chaki S; Iyo M
Eur Neuropsychopharmacol; 2008 Jun; 18(6):414-21. PubMed ID: 17804206
[TBL] [Abstract][Full Text] [Related]
20. The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice.
Boulay D; Bergis O; Avenet P; Griebel G
Neuropsychopharmacology; 2010 Jan; 35(2):416-27. PubMed ID: 19759529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
